Page last updated: 2024-11-04

vorinostat and Fibrosarcoma

vorinostat has been researched along with Fibrosarcoma in 3 studies

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
vorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Fibrosarcoma: A sarcoma derived from deep fibrous tissue, characterized by bundles of immature proliferating fibroblasts with variable collagen formation, which tends to invade locally and metastasize by the bloodstream. (Stedman, 25th ed)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frey, RR1
Wada, CK1
Garland, RB1
Curtin, ML1
Michaelides, MR1
Li, J1
Pease, LJ1
Glaser, KB1
Marcotte, PA1
Bouska, JJ1
Murphy, SS1
Davidsen, SK1
Takahashi, N1
Takeda, K1
Imai, M1
Sampson, ER1
Amin, V1
Schwarz, EM1
O'Keefe, RJ1
Rosier, RN1

Other Studies

3 other studies available for vorinostat and Fibrosarcoma

ArticleYear
Trifluoromethyl ketones as inhibitors of histone deacetylase.
    Bioorganic & medicinal chemistry letters, 2002, Dec-02, Volume: 12, Issue:23

    Topics: Acetylation; Blotting, Western; Breast Neoplasms; Cell Cycle; Enzyme Inhibitors; Fibrosarcoma; Histo

2002
Inhibitory effects of p-dodecylaminophenol on the invasiveness of human fibrosarcoma cell line HT1080.
    Bioorganic & medicinal chemistry, 2013, Oct-01, Volume: 21, Issue:19

    Topics: Aminophenols; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Fibrosarcoma;

2013
The histone deacetylase inhibitor vorinostat selectively sensitizes fibrosarcoma cells to chemotherapy.
    Journal of orthopaedic research : official publication of the Orthopaedic Research Society, 2011, Volume: 29, Issue:4

    Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Fibroblasts; Fibros

2011